moxidectin and Body-Weight

This trial evaluated the effect of maize supplementation on the ingestive behavior, nutrient intake and the resilience against gastrointestinal nematode (GIN) infection of hair sheep in a silvopastoral system containing tropical grasses and legume trees. In addition, it attempted to determine the metabolic cost of the natural GIN infection in supplemented and non-supplemented animals. Twenty-nine 3-month-old lambs (male and female), raised nematode free, were allocated to four groups: I-NS (infected, not supplemented, n = 8), I-S (infected, supplemented with maize at 1.5% live weight (LW), n = 7), T-NS (treated with moxidectin 0.2 mg/kg LW every 28 days, and not supplemented, n = 7) and T-S (treated with moxidectin and supplemented with maize at 1.5% LW, n = 7). During the 70-day trial, fodder intake, fodder selection, LW change (LWC), red blood cell counts (RBC), hemoglobin (Hb), hematocrit (Ht) and eggs per gram of feces (EPG) were measured every 14 days. Supplement consumption was recorded daily. Metabolizable energy (ME) and protein (MP) consumption from the feeds were estimated. Maize supplementation helped to improve the resilience of hair sheep lambs against GIN infections. The I-S and T-NS groups showed similar LWC, RBC, Hb and Ht (P > 0.05) and both were higher than those in the I-NS group (P < 0.05). No difference was found in EPG between the I-NS and the I-S groups (P > 0.05). No effect of sex was observed in the different variables. Although all groups showed low dry matter intake (DMI) (< 2% LW), supplemented groups (T-S and I-S) showed higher total DMI (fodder + maize; P < 0.05), hence higher ME and MP intakes than the non-supplemented groups (T-NS and I-NS). All groups showed similar fodder selection patterns. The estimated metabolic cost of parasitism was ME = 0.70 MJ/day and MP = 9.2 g/day in the I-S animals. Meanwhile, the cost in the I-NS animals was ME = 1.46 MJ/day and MP = 12.71 g/day. Maize supplementation was an economically viable strategy to control GIN compared with no intervention.

Topics: Animal Feed; Animal Husbandry; Animals; Antinematodal Agents; Body Weight; Cynodon; Dietary Supplements; Eating; Energy Metabolism; Fabaceae; Female; Gastrointestinal Diseases; Macrolides; Male; Mexico; Nematode Infections; Sheep; Sheep Diseases; Specific Pathogen-Free Organisms; Zea mays

This laboratory study compared the efficacy of two treatment regimens using an imidacloprid (10%)/moxidectin (2.5%) topical formulation (Advocate, Bayer) on dogs with generalised demodicosis. Sixteen dogs were randomly allocated to two equal groups. One group was treated at 28-day intervals for 12 weeks and the second group at weekly intervals for 15 weeks. Mite numbers were estimated and demodectic lesions were evaluated on each dog before treatment and at approximately 28-day intervals thereafter. Consistently greater reduction in mite numbers was recorded for the weekly treatment regimen. Dogs treated at weekly intervals exhibited markedly fewer clinical signs and greater hair regrowth and weight gain than those treated at 28-day intervals. To assess the safety of a weekly treatment interval in dogs, a study was done in which the investigational compound was administered at weekly intervals at five times the recommended dose for a period of 16 consecutive weeks. Apart from transient erythema at the site of administration in one dog and scaliness of the skin in another, no clinical signs of toxicity could be observed. Assessment of 27 blood parameters indicated that only basophils were outside the reference values on days +13 and +69, during the safety trial period.

Topics: Administration, Topical; Animals; Anthelmintics; Body Weight; Dog Diseases; Dogs; Drug Combinations; Hair; Imidazoles; Macrolides; Mite Infestations; Mites; Neonicotinoids; Nitro Compounds; Skin; Treatment Outcome

The purpose of this study was to assess the efficacy of moxidectin sustained release injectable for dogs (moxidectin SR, Fort Dodge Animal Health) in protecting growing puppies from experimental infection with the heartworm, Dirofilaria immitis, six months after treatment. The study involved 27 puppies, approximately 12 weeks of age at the beginning of the study, with nine puppies in each of three size classes. The small breed class included eight Pekingese and one purpose-bred small breed mongrel; the medium breed class included nine purpose-bred mongrels, and the large breed class included nine puppies with an anticipated adult weight >or=30-35 kg. Both genders were included with no attempt made to have equal numbers of male and female puppies. Puppies were blocked by weight within each size class and randomly assigned to three treatment groups of nine dogs. On Day 0, pups in two groups were injected subcutaneously with moxidectin SR, dosed to deliver 0.17 mg moxidectin/kg b.w. The third group was injected with sterile saline. Personnel making observations were blinded to the treatment status of the animals. Following treatment, puppies were observed for signs of adverse local and systemic reactions. Puppy weights and serum moxidectin levels were also monitored. On Day 180, puppies in all treatment groups were inoculated subcutaneously with 50 third-stage larvae of D. immitis. On Days 348 and 349, puppies were euthanatized and necropsied. Hearts and lungs were examined for adult heartworms. All animals in the saline control group were infected with an arithmetic mean of 39.22 adult heartworms each. Seventeen of 18 dogs in the moxidectin SR-treated groups were uninfected. One treated puppy was infected with a single adult heartworm. This infected individual was from the large breed size class and had the second highest percent increase in body weight. Based on arithmetic means, the heartworm recovery from all treated puppies represents a 99.86% reduction relative to the saline control. There were no adverse local or systemic reactions to treatment in any animal.

Topics: Animals; Body Weight; Delayed-Action Preparations; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Female; Filaricides; Injections, Subcutaneous; Macrolides; Male; Treatment Outcome

Thirty ewes naturally infected with Sarcoptes scabiei var. ovis, were allocated into three groups of 10 animals each. Animals in groups B and C were treated on day 0 and on days 0 and +10, respectively, with moxidectin 1% injectable at a dose of 0.2mg moxidectin/kg body weight (BW). Group A remained untreated. Seven days before treatment, the geometric mean of Sarcoptes scabiei var. ovis per square centimeter of skin in groups A, B and C were not significantly different. From the day of treatment to the end of the trial, the average number of mites/cm(2) increased in untreated animals and decreased in groups B and C, but these values were higher for group C. Active lesions produced by S. scabiei var. ovis consistently increased during the trial in the untreated animals; in group B the minimum count occurred on day +56 this reduction being more evident in group C (no lesions on days +49 and +56). Also in this group, the number of cured animals was 100%, therefore, the application of two treatments with moxidectin (group C) showed higher efficacy than a single treatment (group B). Body condition score decreased in the three experimental groups along the trial. All animals were individually weighed on days -1, +28 and at the end of the trial. No adverse reactions were observed in the animals treated with 0.2mg moxidectin/kg BW.

Topics: Animals; Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Evaluation; Female; Injections, Subcutaneous; Insecticides; Macrolides; Safety; Sarcoptes scabiei; Scabies; Sheep; Sheep Diseases; Skin; Treatment Outcome

The studies wers carried out in ZZD Kolbacz on 14 sows. The experimental groups control and treated consisted of 7 sows each. The sows were treated with Dectomax - 1 ml/33 kg of body weight. The efficacy of sows treatment's was verified with the Wllis-Schlaaf and McMaster method. The studies indicate, that subclinical infection of intestinal nematodes could influence the swine production. The piglets from treated with Dectomax sows were infected in 8% only; when all piglets from non treated sows were infected with nematodes. From treated sows 0.8 more piglet were obtained and the weight gain of litter was after 6 weeks 24.4 kg higher comparing with the control group.

Topics: Animals; Animals, Newborn; Anthelmintics; Body Weight; Feces; Female; Litter Size; Macrolides; Nematode Infections; Poland; Pregnancy; Pregnancy Complications, Parasitic; Swine; Swine Diseases

To assess the control of the cattle tick (Boophilus microplus) and the performance of commercial cattle treated with the macrocylic lactone endectocide, moxidectin, formulated either as an injection or as a pour-on.. Groups of 10-12 tick infested cattle were treated with moxidectin injection, moxidectin pour-on or remained untreated (28-day trials) or were treated with deltamethrin-ethion as a dip (140-day trials). The cattle were exposed to natural tick challenge under field conditions.. Tick numbers on trial cattle were recorded in each trial before the initial treatment and in the 28-day trials at 7, 14, 21 and 28 days or in the 140-day trials, at 28-day intervals before each of the treatments and at the final inspection. Body weights of the cattle were also recorded prior to the initial treatment and at the termination of each trial. Cattle were observed on the day of each treatment and at each inspection for evidence of any reactions to treatment.. 28-day trials: Significant reductions in tick counts were recorded in both treatment groups when compared with cattle in the untreated group. Weight advantage was recorded in the moxidectin treated groups. 140-day trials: All three treatments resulted in zero or low tick counts at each inspection with the exception of the pour-on treatment at week 8 in one trial and week 9 in the other trial. Additional weight gain was recorded for both the moxidectin treated groups, relative to the deltamethrin-ethion dip groups, but was significant only for the pour-on groups. There was no evidence of any local or systemic adverse reaction in any treated cattle in any trial.. Good to excellent control of the cattle tick (Boophilus microplus) was demonstrated with the moxidectin formulations in all trials, the injection being particularly effective. An improved performance was recorded in all trials in cattle treated with both moxidectin formulations when compared with the untreated cattle and with cattle treated with the deltamethrin-ethion dip. There was no evidence of any local or systemic adverse reaction to treatment with either moxidectin formulation.

Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Body Weight; Cattle; Cattle Diseases; Female; Injections; Insecticides; Macrolides; Male; Queensland; Tick Control; Tick Infestations; Ticks

To determine whether (i) the drenching practices of beef producers in the Central Tablelands of NSW utilising short-acting anthelmintics limit the post-weaning growth of heifers and (ii) a single weaning treatment of a long-acting anthelmintic improves post-weaning growth.. Commencing at weaning, 20/100 heifers in each of five herds were injected four times at 90-day intervals with long-acting moxidectin to suppress gastrointestinal nematodes. In year 1 the balance was drenched using the owner's usual commercial practice with short-acting anthelmintics (5 herds) or left undrenched (1 herd). In year 2 the balance was drenched with long-acting moxidectin within 3 months of weaning (4 herds) or with short-acting drenches only (2 herds). At each visit live weight (LW) was recorded and a subsample tested for worm egg count (WEC) and plasma pepsinogen.. In year 1 by 3 and 6 months' post weaning, suppressed heifers were significantly heavier than the undrenched and short-acting groups, and by 12 months were 40 and 28 kg heavier, respectively. In year 2, the LW of the suppressed and long-acting heifers was not different, but by 3 and 6 months both groups were significantly heavier than the short-acting group and by 12 months were 22 kg heavier.. The post-weaning growth of beef heifers treated with short-acting drenches as adopted by Tablelands beef producers was slower than heifers drenched suppressively or with a single long-acting drench at weaning.

Topics: Animals; Anthelmintics; Body Weight; Cattle; Cattle Diseases; Female; Linear Models; Macrolides; New South Wales; Parasite Egg Count; Weaning

Gastrointestinal nematode (GIN) parasite control recommendations are in a state of flux because of the increase in anthelmintic resistant cattle parasites, such as Cooperia spp. In addition, Cooperia spp. infection is typically high in warm-season grass pastures and can affect growth performance of grazing stocker calves in the Gulf Coast Region. This study evaluated the effects of moxidectin pour-on, oxfendazole oral suspension, or a combination of the two given at separate times on infection and performance of weaned beef calves grazing summer forages. Steers (n=42) and heifers (n=31) were stratified by sex, d-11 fecal egg count (FEC), and d-1 shrunk body weight (BW) to one of 10 pastures with four anthelmintic treatments and one control. Treatments included: (1) oxfendazole given on d 0 and moxidectin on d 73 (O+M), (2) moxidectin given on d 0 and oxfendazole on d 73 (M+O), (3) moxidectin given on d 0 (M), (4) oxfendazole given on d 0 (O) and (5) no anthelmintic given (CON). Calves grazed for d-110 beginning May 27th. Response variables were FEC (collected on d-11, 14, 31, 45, 59, 73, 87 and 108), coprocultures (evaluated for d 87 and 108), final shrunk BW, shrunk BW gain, average daily gain (ADG), and full BW gain (collected on d 31, 59, 73, 87, and 108). Calves treated with either oxfendazole (O+M and O) or moxidectin (M+O and M) on d 0 had significantly lower (P<0.001) FEC than the CON calves on d 14, 31 and 45. However, the M+O treated calves had significantly higher (P<0.001) FEC than both oxfendazole treated groups. In addition, calves treated with a second dewormer on d 73 (O+M and M+O) had significantly lower (P<0.001) FEC by d 87 than the CON or M treated calves. Shrunk BW gain and ADG were significantly greater (P=0.005) for the O+M compared to the M treated and CON calves, but comparable with the M+O and O treated calves, respectively. Coprocultures sampled on d 87 and 108 for calves not receiving a second dewormer were predominantly Cooperia spp. and Ostertagia spp. On d 87, no larvae were recovered from the M+O treated calves, whereas the O+M treated calves had 94% Cooperia spp. and 3% Ostertagia spp. recovered. Providing a benzimidazole with a macrocyclic lactone given at two different periods may provide better GIN parasite control and improve animal gains for stocker calves grazing warm-season grass pastures.

Topics: Animals; Anthelmintics; Benzimidazoles; Body Weight; Cattle; Cattle Diseases; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Macrolides; Male; Nematode Infections

To compare the effectiveness of a single long-acting injection of moxidectin, given in either summer or winter, with a two-summer ('standard') treatment strategy for controlling gastrointestinal nematodes in spring-lambing Merino ewes.. A replicated study over 2 years in the high winter rainfall environment of western Victoria.. Measures of worm infection were worm egg counts of ewes and total worm counts of tracer lambs. Measures of production were body weight, proportion of pregnant ewes and number of weaned lambs.. The egg counts of ewes given the standard strategy followed a characteristic pattern, rising to 300 to 600 eggs per gram before the second summer treatment in February. During this time, ewes given long-acting moxidectin in December had zero or negligible counts. There were no consistent differences between tracer worm counts or production measures for the two groups treated in summer, but when data from both years were pooled, the total egg output from December to May was significantly lower for ewes treated with long-acting moxidectin in December. Ewes not treated during summer had lower body weights, and higher worm egg counts and tracer worm counts, showing that this was not a suitable strategy at that time of the year. However, following treatment with long-acting moxidectin in winter, ewes had rapid compensatory weight gain and lower egg output than ewes treated in summer.. A single injection of long-acting moxidectin in December is an effective treatment strategy for Merino ewes lambing in spring.

Topics: Analysis of Variance; Animals; Antinematodal Agents; Body Weight; Feces; Female; Larva; Macrolides; Parasite Egg Count; Pregnancy; Pregnancy Complications, Parasitic; Seasons; Sheep; Sheep Diseases; Trichostrongyloidea; Trichostrongyloidiasis; Victoria

The study was undertaken to evaluate adverse effects of larvicidal treatment in horses naturally infected with cyathostomins. Out of 24 ponies kept on pasture, four animals were housed in September and anthelmintically cured to serve as worm-free controls (group C-0). The others were housed in December. Eight animals each were treated 8 weeks later with 5 x 7.5mg/kg fenbendazole (FBZ) or 1 x 0.4 mg/kg moxidectin (MOX). Four animals remained untreated (group C-i). Two, 4, 6 and 14 days after the end of treatment two animals of each of the treated groups were necropsied together with group C-0 and C-i animals. Infected animals before treatment showed weight loss, eosinophilia, increased plasma protein and globulin contents. Treatment was followed by weight gain and temporal plasma protein and globulin increase. Proportions of CD4+ and CD8+ T lymphocytes in the peripheral blood did not differ between the groups before treatment but dropped significantly temporally after FBZ treatment. Group C-0 was worm-free at necropsy. Group C-i animals contained variable numbers of luminal and tissue cyathostomins. Histological sections showed larval stages in the lamina propria und submucosa surrounded by macrophages. Either treatment was effective against luminal parasites and reduced the number of larvae in the bowel wall beginning 4-6 days after FBZ and 6-14 days after MOX treatment. Histologically, as a first reaction after FBZ application T lymphocytes accumulated around morphologically intact L4 in the submucosa. Subsequently T lymphocytes associated with eosinophils infiltrated the submucosa. Parasites became enclosed by granulomas with eosinophils adhering to and invading the larvae which started to disintegrate on day 4. Later on, particularly on day 14 inflammation extended into the mucosa and was frequently associated with ulcerations. Third stage larvae in general and L4 in the lamina propria, however, seemed not to be affected until day 14 and even then, parasites did usually not generate extensive inflammation. After MOX treatment severe morphologically detectable alterations of tissue larvae could not be observed earlier than day 14. Different from FBZ treatment, larvae disintegrated and were obviously resorbed without causing severe inflammation in the gut wall. In conclusion treatment with either drug was efficacious against tissue larvae of cyathostomins but there may be different clinical consequences: in contrast to MOX effects, killing of larvae due

Topics: Animals; Anthelmintics; Body Weight; CD4-CD8 Ratio; Female; Fenbendazole; Horses; Intestinal Mucosa; Larva; Macrolides; Male; Random Allocation; Strongyle Infections, Equine; Strongylus; Time Factors; Treatment Outcome

The chemoprophylactic efficacy of a single dose of the 10% long acting (LA) injectable formulation of moxidectin on nematode infections in calves, was evaluated. Two similar groups of 11 female, first grazing season Holstein calves were turned out in early May on separate plots of a single, naturally infected pasture. Until 56 days post-treatment (pt), the percentage reduction in faecal egg output was 100%, remaining above 90% during the entire trial, except for day 126 pt. More than 90% of the larvae in the treated group were identified as Cooperia until 140 days after treatment and more than 70% during the rest of the trial, whereas in the control group Cooperia was the most abundant species until day 84 pt and Ostertagia from 126 days pt onwards. The reduction in faecal egg output in the treated group was reflected in the mean pepsinogen levels being below the pathogenic threshold at the end of the grazing season (1.8 units of tysrosine (U tyr)) and the absence of diarrhoea during the second half of the grazing season. In the control group pepsinogen levels remained high (mean: 5.5 U tyr) and prolonged diarrhoea occurred in the second half of the grazing season. Furthermore, the weight gain for the treated group at the end of the grazing season was 41.9 kg higher than for the control group. At necropsy, the reduction in O. ostertagi worm burden in the treated group was 97.5% compared to the control group, while the reduction in C. oncophora worm burden was 57%. An additional benefit of the long acting parasitological control, was reduced pasture contamination.

Topics: Animals; Anthelmintics; Belgium; Body Weight; Cattle; Cattle Diseases; Diarrhea; Feces; Female; Injections, Subcutaneous; Intestinal Diseases, Parasitic; Macrolides; Nematoda; Nematode Infections; Parasite Egg Count; Poaceae; Random Allocation

The aim of the study was to determine the effect of alternative management interventions on levels of nematodes and the condition of working donkeys in South Africa. Twenty-four adult donkeys (Equus asinus) within an area of 200km radius were randomly allocated to eight paddocks. Two replicates each of three management interventions together with a control group were tested in a 16-month study. The interventions included monthly removal of feces from paddocks where the donkeys grazed, a pre-winter moxidectin treatment, and a combination of a pre-winter moxidectin treatment and monthly fecal removal. The influence of the different interventions on the nematode fecal egg counts, animal live weights, body condition scores and general blood chemistry were compared. In addition, herbage samples were collected from the pastures in each paddock to determine the number of third-stage larvae (L(3)) per kg dry matter. At the end of the study worm recoveries and counts were performed on eight of the animals following euthanasia. The cyathostomes represented the largest portion of the helminth species composition in both the fecal egg counts and larval cultures. Monthly fecal removal alone did not significantly reduce the L(3) on pasture and consideration of more frequent removal is discussed. Pre-winter moxidectin treatment resulted in a 100% reduction in fecal egg counts, an average egg reappearance period of 42-55 days, a reduced average egg count for up to 8 months, and reduced total helminth burdens in all the treated donkeys. It also resulted in improved live weights, hemoglobin concentration, packed cell volumes and to some extent body condition score of the donkeys.

Topics: Animal Husbandry; Animals; Anthelmintics; Anti-Bacterial Agents; Body Weight; Equidae; Feces; Female; Helminthiasis, Animal; Larva; Macrolides; Male; Parasite Egg Count; Random Allocation; Seasons; South Africa; Treatment Outcome

Forty-eight dairy ewes and 45 lambs naturally infested with sarcoptic mange, were divided into three equal groups and treated with moxidectin 1% inj. sol. at a dose rate of 0.2 mg moxidectin kg(-1) bodyweight once or twice ten days apart. During the study, the skin lesions were scored and the number of mites recovered in facial skin scrapings from the animals were recorded. Moxidectin was found to be effective against ovine sarcoptic mange, when given twice; the percentage reduction of mites was 100% (p < 0.0001) and the skin lesions disappeared completely (p = 0.0001). In sheep treated once only, the percentage reduction of mites varied from 75% to 92%. Treated ewes produced up to 22.4% more milk than the infested ones (p = 0.0001). Treated lambs had up to 15% greater final weight and up to 23.7% more growth than infested controls (p = 0.0001). It is concluded that two injections of moxidectin 1% inj. sol. at a dose rate of 0.2 mg kg(-1) bodyweight, given ten days apart, were effective against ovine sarcoptic mange. Furthermore, it is considered that sarcoptic mange adversely affects the production of the infested animals.

Topics: Animals; Anti-Bacterial Agents; Body Weight; Female; Injections; Insecticides; Lactation; Macrolides; Milk; Sarcoptes scabiei; Scabies; Sheep; Sheep Diseases; Skin

To evaluate the safety of moxidectin administration at doses of 30, 60, and 90 microg/kg of body weight (10, 20, and 30 times the manufacturer's recommended dose) in avermectin-sensitive Collies.. 24 Collies.. Collies with mild to severe reactions to ivermectin challenge (120 mg/kg; 20 times the recommended dose for heartworm prevention) were used. Six replicates of 4 dogs each were formed on the basis of body weight and severity of reaction to ivermectin test dose. Within replicates, each dog was randomly allocated to treatment with oral administration of 30, 60, or 90 microg of moxidectin/kg or was given a comparable volume of placebo tablet formulation. Dogs were observed hourly for the first 8 hours and twice daily thereafter for 1 month for signs of toxicosis.. Signs of toxicosis were not observed in any control group dog throughout the treatment observation period. Likewise, signs of toxicosis were not observed in any dog receiving moxidectin at 30, 60, or 90 microg/kg.. The moxidectin formulation used in the study reported here appears to have a wider margin of safety than ivermectin or milbemycin in avermectin-sensitive Collies.

Topics: Administration, Oral; Animals; Anthelmintics; Anti-Bacterial Agents; Body Weight; Confidence Intervals; Dogs; Dose-Response Relationship, Drug; Female; Ivermectin; Macrolides; Male; Random Allocation

Psoroptes ovis counts, extent of lesions (clinical index: ClinI), daily weight gains (DWGs) and anti-P. cuniculi antibody titres in ELISA were recorded during seven therapeutic field trials. Relationship between these different data were studied. The differences between the mean DWG of treated and untreated control animals of the different trials ranged from 39 to 1206 g/day. Data were pooled for statistical analysis and the influence of trial conditions (management of the herd, farm, treatment) was extracted from each individual data by subtracting, from the DWG of each animal, the mean DWG of its trial. Such data were called daily weight gain over the trial mean (DWG/TM). Multiple regression of DWG/TM, calculated over the period between the clinical examinations in control animals (n = 40), on clinical indices and sex demonstrated a significant DWG/TM reduction per percentage of affected body surface according to the following equation: DWG/TM (in g/day)= 135-22 ClinI(0)-13 ClinI(28/35)-70 (if male) (R2 adjusted = 0.39), where ClinI(0) and ClinI(28/35) are the clinical indices recorded respectively at the beginning (day 0) and at the end (day 28 or 35) of the experimental period during which the animals were left untreated. A nonsignificant relationship (R2 adjusted = 0.07) was found between the antibody titres on day 28 or 35 and the individual DWG/TM This would suggest that serology could be used to estimate the prevalence of the disease on a local or national basis but not to calculate its economic impact.

Topics: Animals; Anti-Bacterial Agents; Antibodies; Body Weight; Cattle; Cattle Diseases; Enzyme-Linked Immunosorbent Assay; Female; Insecticides; Ivermectin; Macrolides; Male; Mite Infestations; Mites; Regression Analysis; Weight Gain